What is Cumberland Pharmaceuticals's current debt?

Cumberland Pharmaceuticals (CPIX) reported current debt of $0 in Q4 2025.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Cumberland Pharmaceuticals CPIX Current Debt

Current Debt at other companies

Baxter InternationalBAX

$0-100%

Rigel PharmaceuticalsRIGL

$22.5M—

RFL

Rafael Holdings, Inc.RFL

$21.9M+995%

Opko HealthOPK

$1.53M+7.2%

OrganonOGN

$16M-20.0%

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+142%

Enterprise value$90.91M+212%

P/S2.3×+1.4×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's current debt?: Cumberland Pharmaceuticals (CPIX) reported current debt of $0 in Q4 2025.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.